July 21st, 2024

Notable companies set to report their financial results on Tuesday, July 23, include: Tesla, Inc. (Nasdaq: TSLA), the electric vehicle and clean energy giant, will post its financial results for the second quarter of 2024 after the market closes. . Read more

January 21st, 2024

On Wednesday, January 24, a lineup of major companies is set to reveal their financial performances: Tesla, Inc. (Nasdaq: TSLA), the electric vehicle and clean energy company, will release its financial results for the fourth quarter of 2023 after. Read more

October 18th, 2023

Tesla, Inc. (Nasdaq: TSLA), an electric vehicle and clean energy company, posted third-quarter 2023 earnings of $0.66 per share, falling short of the consensus EPS estimate of $0.73. The company's quarterly sales totaled $23.35 billion, below analyst. Read more

October 14th, 2023

On Wednesday, October 18, the spotlight turns to these key companies as they prepare to unveil their financial results: Tesla, Inc. (Nasdaq: TSLA), the renowned electric vehicle manufacturer, is poised to post its financial results for the third q. Read more

September 11th, 2023

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) has reported promising results from its Phase 3 PATHFNDR-1 study evaluating paltusotine, an oral once-daily investigational compound designed for acromegaly treatment. The study achieved its primary endp. Read more

September 05th, 2023

Tesla, Inc. (Nasdaq: TSLA), a leading electric vehicle and clean energy company, has been granted two new patents by the United States Patent and Trademark Office (USPTO): - Patent No. US-11749842-B2, titled "Cell with a tabless electrode" and; . Read more

July 20th, 2023

Tesla, Inc. (Nasdaq: TSLA) has released its second-quarter 2023 financial results, surpassing earnings expectations with an adjusted EPS of $0.91 compared to the consensus estimate of $0.82. The company's quarterly revenues surged 47% year-over-year . Read more

July 02nd, 2023

Tesla, Inc. (Nasdaq: TSLA) announced its vehicle production and deliveries for the second quarter of 2023. The company produced 479,700 vehicles and delivered 466,140 vehicles during this period, marking an increase from the previous quarter's produc. Read more

June 27th, 2023

AeroVironment, Inc. (Nasdaq: AVAV) reported fourth-quarter fiscal 2023 adjusted EPS of $0.99, slightly below the consensus estimate of $1.01. Looking ahead to the full-year fiscal 2024, the company anticipates revenue ranging between $630 million . Read more

June 26th, 2023

XPeng Inc. (NYSE: XPEV), a leading Chinese electric vehicle manufacturer, is poised to have a significant impact on the automotive market with the highly anticipated launch of its XPENG G6 Ultra Smart Coupe SUV. This revolutionary vehicle, developed . Read more

June 22nd, 2023

GMS Inc. (NYSE: GMS) announced its fourth-quarter fiscal 2023 results, surpassing expectations with an adjusted EPS of $2.11 compared to the consensus estimate of $1.89. The company reported quarterly sales of $1.30 billion, exceeding the consensus r. Read more

June 20th, 2023

Nuwellis, Inc. (Nasdaq: NUWE) has partnered with DaVita Inc. (NYSE: DVA) through a Supply and Collaboration Agreement to introduce Aquadex ultrafiltration therapy for the treatment of adult patients with congestive heart failure in select U.S. market. Read more

June 20th, 2023

Tesla, Inc. (Nasdaq: TSLA), a renowned electric vehicle and clean energy company, is increasing the protection of its intellectual property with two new patents awarded by The United States Patent and Trademark Office (USPTO). The first patent, No. Read more

June 13th, 2023

Tesla, Inc. (Nasdaq: TSLA), a renowned electric vehicle and clean energy company, has been awarded U.S. Patent No. US 11,675,358 B2 by The United States Patent and Trademark Office (USPTO).  This patent, titled "Autonomous driving system emer. Read more

June 12th, 2023

iBio, Inc. (NYSE American: IBIO) has partnered with the National Institute of Allergy and Infectious Diseases (NIAID) to explore the potential of the company's AI-driven epitope steering platform in developing a vaccine for Lassa fever, a severe and . Read more